- Case Report
Multifocal subdural hematomas as the presenting sign of acquired hemophilia A: a case report
BMC Research Notesvolume 7, Article number: 134 (2014)
Acquired hemophilia A (AHA) is a rare coagulopathy linked to a variety of etiologies including autoimmune diseases, neoplasms, diabetes, respiratory diseases, and the post-partum state. While bleeding in AHA is often seen in mucocutaneous or intramuscular locations, intracranial and intraspinal bleeds are exceedingly rare.
We report an unusual case of spontaneous multifocal subdural hematomas in a 25 year old Asian woman with lupus who presented with headache and backache, and was found to have an elevated partial thromboplastin time (PTT) level and new diagnosis of AHA.
Subdural hematomas as the initial sign of AHA are all but unknown in the medical literature. We bring this entity to the attention of the neurology community because lumbar puncture and/or conventional angiogram are often indicated in the work-up of idiopathic multifocal subdural hematomas, but may be dangerous in patients with AHA.
Acquired hemophilia A (AHA) is a rare disorder (approximately 1 in 1 million persons per year) but carries a significant mortality of 8–22%. While bleeding in AHA most commonly involves mucocutaneous or intramuscular locations, it can also involve the gastrointestinal or genitourinary tracts. Hemarthrosis, which is considered a hallmark of congenital Hemophilia, is rarely encountered in AHA. While intracranial hemorrhage has been well documented in congenital hemophilia A[3–6], there are only a limited number of publications on intracranial bleeds in acquired hemophilia A[7–10], suggesting that it is a very rare phenomenon. Diagnosis is made based on the finding of 1) an elevated partial thromboplastin time (PTT) which does not correct after 2 hours of mixing with normal plasma (mixing study), 2) no administration of heparin, which can be determined by a prolonged thrombin time but normal reptilase time, 3) negative testing for lupus anticoagulants, and 4) the presence of an inhibitor as shown on the Bethesda assay, which mixes serial dilutions of the patient’s blood with normal plasma[11, 12]. The etiology is idiopathic in 50% and post-partum in 10%, with the remaining 40% covering a wide spectrum of autoimmune, allergic, neoplastic, diabetic, and respiratory diseases[11, 13]. Treatment in part depends on the underlying etiology of the AHA, with pregnancy- or allergy-related AHA often responding to steroids or cyclophosphamide and resolving spontaneously, tumor-related AHA often depending on treatment of the malignancy, and autoimmune-related AHA often requiring stronger immunosuppression and rarely resolving spontaneously.
A 25 year old Asian woman with a history of lupus presented to the emergency room with headaches not responding to over the counter analgesics. The headaches started 6 days prior, with no reported history of trauma. She described the headaches as a gradual onset of intermittent 10/10 sharp right-sided head pain which lasted for several seconds only, and occurred multiple times per day. The pain occasionally spread to the right neck with a pulsating quality but without tinnitus. There was no postural component, no associated migrainous features (including nausea, vomiting, photophobia, phonophobia, osmophobia, or vision changes), and no trigeminal autonomic symptoms (including facial pallor, facial flushing, lacrimation, or rhinorrhea). In addition, she occasionally had brief lower back spasmic-type pain with no radiation. She did not have any symptoms of coagulopathy including easy bleeding, GI bleeds, epistaxis, or hemoptysis. She carried a diagnosis of lupus with discoid rash and arthralgia as predominant symptoms for which she was taking prednisone 15 mg daily and mycophenylate 500 mg BID (she had self-discontinued the mycophenylate 1 week prior to admission), and a family history significant for a sister who died of anemia of an unknown etiology at the age of 24. Our patient’s neurologic examination was unremarkable.
Given the new onset of severe unilateral headaches without clear symptoms of a primary headache syndrome, head imaging was performed. Brain MRI revealed bilateral infracerebellar and right pre-pontine extra-axial collections most consistent with hematomas (Figure 1A and B), and basic laboratory studies were significant for an isolated elevation of PTT at 74 with a normal CBC, chemistry panel, liver panel, INR, and urine toxicology screen. Additional imaging included a brain MR venogram with no venous thrombosis, a CT angiogram with no vasculitis or aneurysms, and a spinal MRI with additional subdural hematomas in her cervical and lumbar regions (Figure 1C and D). Work-up of her elevated PTT revealed a clotting mixing study that failed to correct with a 1:1 ratio to plasma (suggestive of the presence of an inhibitor) and an undetectable factor 8 level, consistent with AHA (one month after treatment the factor 8 activity level was 36% with a normal range of 56–191%). Lupus anticoagulant testing had previously been performed twice over 6 months, with an initial indeterminate anti-cardiolipin IgG of 17 that was normal at 10 on rechecking, and normal levels of anti-cardiolipin IgM, anti-beta-2-glycoprotein IgG, anti-beta-2-glycoprotein IgM, Russell Viper Venom Test, and Russell Viper Venom confirmation testing. Urine pregnancy testing was negative and she was not post-partum. Infectious labs revealed a positive beta-D-glucan and negative galactomannan, but a brochoalveolar lavage that was positive only for candida and rare gram-positive cocci and was negative for acid fast bacilli, other fungi, and viral cultures. Other infectious testing was negative including a nasopharyngeal swab for influenza A and B, urine cultures, blood cultures, histoplasma antigen, and a hepatitis panel. She was started on recombinant factor 7a and rituximab, with repeat imaging showing resolving hematomas.
Of the multiple etiologies of AHA[11, 13], our patient’s disease was most likely related to her systemic lupus erythematosus. Our patient’s headache and backache description, specifically the very brief and intermittent nature of her symptoms, is unusual for pain related to mass lesions. One previous case report of subdural hematomas and AHA described more classic symptoms of headache and drowsiness, but given the paucity of cases in the literature, it is difficult to say if there is any characteristic headache associated with AHA.
On initial work-up of our patient, a variety of diagnostic tests were discussed. The differential diagnosis for non-traumatic intracranial and intraspinal subdural hematomas is broad, and etiologies include neoplasms such as myelodysplastic disorders or meningiomas, infections such as mycotic aneurysms, vascular diseases such as arteriovenous malformations, aneurysms, or primary CNS vasculitis, and coagulopathies such as idiopathic thrombocytopenic purpura. Thus a thorough investigation for non-traumatic subdural hematoma may lead to a lumbar puncture or a conventional angiogram. The risk of bleeding after lumbar puncture is not known in patients with AHA, or even for similar procedures such as epidural injections in more common coagulopathies. However the risk of bleeding after lumbar puncture is presumably higher for patients with untreated AHA than for the general population. Before performing a lumbar puncture on patients who are otherwise stable, providers might consider initiating treatment or awaiting results of the AHA testing. Similarly conventional angiogram may pose unnecessary risks in patients with AHA, and deferral or avoidance of angiogram should also be considered, especially if other vessel imaging such as MRA or CTA is not suggestive of vascular malformations.
The findings of subdural hematoma with an unexplained elevated PTT should prompt further work-up for AHA with mixing studies at 0.1 and 2 hours, phospholipid studies for lupus anticoagulant, and the Bethesda assay for the quantification of inhibitors (Figure 2)[11, 12, 22]. In patients with suspected AHA with any pain complaint, such as lower back pain in our case, imaging should be considered to look for additional bleeds and to lend stronger support for starting immediate factor replacement therapy. In the acute setting, if emergent neurosurgical evacuation of these patients is required, factor 7a should be considered for uncontrolled intra-operative bleeding.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CRM: Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007, 109: 1870-1877. 10.1182/blood-2006-06-029850.
Yee TT, Taher A, Pasi KJ, Lee CA: A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol. 2000, 22: 275-278. 10.1046/j.1365-2257.2000.00316.x.
Philipp C: The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology Am Soc Hematol Educ Program. 2010, 2010: 191-196. 10.1182/asheducation-2010.1.191.
Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L: Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol. 2011, 152: 211-216. 10.1111/j.1365-2141.2010.08469.x.
Nakar C, Cooper DL, DiMichele D: Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008). Haemophilia. 2010, 16: 625-631.
Ljung RCR: Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2008, 140: 378-384. 10.1111/j.1365-2141.2007.06949.x.
Bonnaud I, Saudeau D, de Toffol B, Autret A: Recurrence of spontaneous subdural haematoma revealing acquired haemophilia. Eur Neurol. 2003, 49: 253-254. 10.1159/000070200.
Micic D, Williams EC, Medow JE: Cerebellar hemorrhage as a first presentation of acquired hemophilia A. Neurocrit Care. 2011, 15: 170-174. 10.1007/s12028-010-9489-0.
Mashiko R, Yamamoto T, Sato M, Noguchi S, Matsumura A: Acquired hemophilia first manifesting as life-threatening intracranial hemorrhage: case report. Neurol Med Chir (Tokyo). 2009, 49: 93-95. 10.2176/nmc.49.93.
Saito R, Takahashi T, Endo H, Kimura N, Kaneko U: [A case of subarachnoid hemorrhage complicated by acquired hemophilia]. No Shinkei Geka. 2009, 37: 1215-1219.
Shetty S, Bhave M, Ghosh K: Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev. 2011, 10: 311-316. 10.1016/j.autrev.2010.11.005.
Collins P, Baudo F, Huth-Kühne A, Ingerslev J, Kessler CM, Castellano MEM, Shima M, St-Louis J, Lévesque H: Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010, 3: 161-10.1186/1756-0500-3-161.
Franchini M, Gandini G, Di Paolantonio T, Mariani G: Acquired hemophilia A: a concise review. Am J Hematol. 2005, 80: 55-63. 10.1002/ajh.20390.
Ichimura S, Horiguchi T, Inoue S, Yoshida K: Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms. J Neurosci Rural Pract. 2012, 3: 98-99. 10.4103/0976-3147.91978.
Da Rocha AJ, Saade N, da Silva AZ: Meningioma associated with non-traumatic subdural hematoma: an outstanding appearance of this common intracranial tumor. Arq Neuropsiquiatr. 2013, 71: 417-10.1590/0004-282X20130052.
Barami K, Ko K: Ruptured mycotic aneurysm presenting as an intraparenchymal hemorrhage and nonadjacent acute subdural hematoma: case report and review of the literature. Surg Neurol. 1994, 41: 290-293. 10.1016/0090-3019(94)90176-7.
Kominato Y, Matsui K, Hata Y, Matsui K, Kuwayama N, Ishizawa S, Takizawa H: Acute subdural hematoma due to arteriovenous malformation primarily in dura mater: a case report. Leg Med (Tokyo). 2004, 6: 256-260. 10.1016/j.legalmed.2004.06.004.
Ishikawa E, Sugimoto K, Yanaka K, Ayuzawa S, Iguchi M, Moritake T, Kobayashi E, Nose T: Interhemispheric subdural hematoma caused by a ruptured internal carotid artery aneurysm: case report. Surg Neurol. 2000, 54: 82-86. 10.1016/S0090-3019(00)00262-7.
Fu M, Omay SB, Morgan J, Kelley B, Abbed K, Bulsara KR: Primary central nervous system vasculitis presenting as spinal subdural hematoma. World Neurosurg. 2012, 78: 192.E5-192.E8.
Lee MS, Kim WC: Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: report of seven patients and a meta-analysis. Neurology. 1998, 50: 1160-1163. 10.1212/WNL.50.4.1160.
Choi S, Brull R: Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses. Anesth Analg. 2009, 109: 648-660. 10.1213/ane.0b013e3181ac13d1.
Lossing S, Kasper K, Feinstein I: Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 1977, 49: 793-797.
We thank our patient who was incredibly generous with her time after her hospital discharge.
The authors (M.J. Burish, A. Aysenne, and V. Singh) declare that they have no competing interests.
MJB contributed by drafting and revising the manuscript for content, and analysis/interpretation of data. He also assisted in acquisition of data. AA contributed by revising the manuscript for content, and analysis/interpretation of data. She also assisted in acquisition of data. VS contributed by revising the manuscript for content, and analysis/interpretation of data. She also assisted in acquisition of data. All authors read and approved the final manuscript.
About this article
- Acquired hemophilia A
- Nontraumatic subdural hematoma
- Intracranial hemorrhage
- Secondary headache syndrome
- Spinal cord
- Critical care